Amyloid-beta aggregation inhibitor

This page covers all Amyloid-beta aggregation inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Amyloid-beta (Aβ).

Targets

Amyloid-beta (Aβ)

Phase 3 pipeline (1)

• Tramiprosate (3APS) · Bellus Health Inc. - a GSK company · Neurology
  Tramiprosate inhibits amyloid-beta aggregation and promotes its clearance, reducing amyloid plaque formation in the brain.

Patent intelligence

• amyloid beta aggregation inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates